TNF Alpha Inhibitors Global Market Report 2021 - By Drug (Remicade (Infliximab), Enbrel (Etanercept), Humira (Adalimumab), Cimzia (Certolizumab Pegol), Simponi (Golimumab), By Route Of Administration (Oral, Subcutaneous, Intravenous), By Disease Type (Inflammatory Bowel Disease, Psoriatic Arthritis, Ulcerative Colitis (UC), Rheumatoid Arthritis, Ankylosing Spondylitis), COVID-19 Growth And Change

aboutimg
Purchase Options
Request Sample
Request For Discount
FAQ
Infoimg

Starting Price : $5000.00 | Pages : 175 | Published : March 2021 | SKU CODE : 7724 | Delivery Time: 2-3 business days | Format :


Description Table Of Contents Tables & Figures Market Insights Related Reports

The TNF alpha inhibitors market consists of sales of tumor necrosis factor-alpha (TNF-a) inhibitors by entities that manufacture TNF alpha inhibitors. TNF alpha inhibitors are a group of medicines that conquer the body’s natural response to TNF, a protein produced by white blood cells, involved in early inflammatory events. These are important treatments in the number of inflammatory conditions including spondylarthritis, psoriasis, rheumatoid arthritis (RA), and inflammatory bowel disease (IBD).

The TNF alpha inhibitors market covered in this report is segmented by drug into remicade (infliximab), enbrel (etanercept), humira (adalimumab), cimzia (certolizumab pegol), simponi (golimumab). The TNF alpha inhibitors market is also segmented by route of administration into oral, subcutaneous, intravenous, others and by disease type into inflammatory bowel disease, psoriatic arthritis, ulcerative colitis (UC), rheumatoid arthritis, ankylosing spondylitis, others.

The global TNF alpha inhibitors market is expected to grow from $38.85 billion in 2020 to $40.33 billion in 2021 at a compound annual growth rate (CAGR) of 3.8%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The TNF alpha inhibitors market is expected to reach $45.74 billion in 2025 at a CAGR of 3%.

The growing prevalence of inflammatory diseases such as inflammatory bowel disease and psoriasis is a key factor driving the growth of the TNF alpha inhibitors market. Tumor necrosis factor-alpha (TNF alpha) inhibitors are commonly used in gastroenterology, dermatology and rheumatology for the treatment of various immune-mediated inflammatory diseases. Globally, the prevalence of inflammatory bowel disease (IBD) is about 0.5-24.5 cases for ulcerative colitis per 100,000 person-years and 0.1-16 cases for Crohn's disease per 100,000 person-years, and overall, IBD prevalence is 396 cases per 100,000 people each year. Thus, the increasing number of cases of inflammatory diseases increases the demand for TNF alpha inhibitors contributing to the growth of the market.

 

The adverse side effects of TNF alpha inhibitors on patients are expected to limit the growth of the TNF alpha inhibitors market. The multiple adverse effects of TNF alpha inhibition identified by clinical trials and post-marketing surveillance include injection site reactions, neutropenia, infusion reactions, and infections. According to the U.S. Food and Drug Administration (FDA), TNA alpha inhibitors can cause serious infections in people with weaker immune systems or low resistance levels. The infections can be bacterial, mycobacterial, fungal, and viral leading to various diseases such as tuberculosis, histoplasmosis, candidiasis, blastomycosis, and hepatitis B. These side effects force patients to prefer alternatives such as non-TNF biologics, which hampers the growth of the market.

 

In May 2020, AbbVie Inc, a US-based biopharmaceutical company, completed the acquisition of Allergan plc for an amount of $63 billion. The acquisition is expected to expand and diversify AbbVie Inc’s revenue base and its existing immunology portfolio. Allergan plc is an Ireland-based pharmaceutical company engaged in manufacturing and marketing drugs and medical devices in the areas of the central nervous system, eye care, medical aesthetics, and gastroenterology.

 

Major players in the TNF alpha inhibitors market are AbbVie Inc., Amgen Inc., Johnson & Johnson Services, Inc., UCB S.A, Novartis International AG, Pfizer, Inc., Merck & co., Inc., Janssen Biotech, Ablynx, and Momenta Pharmaceuticals.

The regions covered in the TNF alpha inhibitors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the TNF alpha inhibitors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The global TNF alpha inhibitors market is segmented -

1) By Drug: Remicade (Infliximab), Enbrel (Etanercept), Humira (Adalimumab), Cimzia (Certolizumab Pegol), Simponi (Golimumab)

2) By Route Of Administration: Oral, Subcutaneous, Intravenous, Others

3) By Disease Type: Inflammatory Bowel Disease, Psoriatic Arthritis, Ulcerative Colitis (UC), Rheumatoid Arthritis, Ankylosing Spondylitis, Others

    Table Of Contents

    1. Executive Summary

    2. TNF Alpha Inhibitors Market Characteristics

    3. TNF Alpha Inhibitors Market Trends And Strategies

    4. Impact Of COVID-19 On TNF Alpha Inhibitors

    5. TNF Alpha Inhibitors Market Size And Growth

    5.1. Global TNF Alpha Inhibitors Historic Market, 2015-2020, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global TNF Alpha Inhibitors Forecast Market, 2020-2025F, 2030F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. TNF Alpha Inhibitors Market Segmentation

    6.1. Global TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Remicade (infliximab)

    Enbrel (etanercept)

    Humira (adalimumab)

    Cimzia (certolizumab pegol)

    Simponi (golimumab)

    6.2. Global TNF Alpha Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Oral

    Subcutaneous

    Intravenous

    Others

    6.3. Global TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Inflammatory Bowel Disease

    Psoriatic Arthritis

    Ulcerative Colitis (UC)

    Rheumatoid Arthritis

    Ankylosing Spondylitis

    Others

    7. TNF Alpha Inhibitors Market Regional And Country Analysis

    7.1. Global TNF Alpha Inhibitors Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    7.2. Global TNF Alpha Inhibitors Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8. Asia-Pacific TNF Alpha Inhibitors Market

    8.1. Asia-Pacific TNF Alpha Inhibitors Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8.3. Asia-Pacific TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    9. China TNF Alpha Inhibitors Market

    9.1. China TNF Alpha Inhibitors Market Overview

    9.2. China TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    9.3. China TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    10. India TNF Alpha Inhibitors Market

    10.1. India TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    10.2. India TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11. Japan TNF Alpha Inhibitors Market

    11.1. Japan TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11.2. Japan TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12. Australia TNF Alpha Inhibitors Market

    12.1. Australia TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12.2. Australia TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13. Indonesia TNF Alpha Inhibitors Market

    13.1. Indonesia TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13.2. Indonesia TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14. South Korea TNF Alpha Inhibitors Market

    14.1. South Korea TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14.2. South Korea TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15. Western Europe TNF Alpha Inhibitors Market

    15.1. Western Europe TNF Alpha Inhibitors Market Overview

    15.2. Western Europe TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15.3. Western Europe TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16. UK TNF Alpha Inhibitors Market

    16.1. UK TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16.2. UK TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17. Germany TNF Alpha Inhibitors Market

    17.1. Germany TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17.2. Germany TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18. France TNF Alpha Inhibitors Market

    18.4. France TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18.5. France TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19. Eastern Europe TNF Alpha Inhibitors Market

    19.1. Eastern Europe TNF Alpha Inhibitors Market Overview

    19.2. Eastern Europe TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19.3. Eastern Europe TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20. Russia TNF Alpha Inhibitors Market

    20.1. Russia TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20.2. Russia TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21. North America TNF Alpha Inhibitors Market

    21.1. North America TNF Alpha Inhibitors Market Overview

    21.2. North America TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21.3. North America TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22. USA TNF Alpha Inhibitors Market

    22.1. USA TNF Alpha Inhibitors Market Overview

    22.2. USA TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22.3. USA TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23. South America TNF Alpha Inhibitors Market

    23.1. South America TNF Alpha Inhibitors Market Overview

    23.2. South America TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23.3. South America TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24. Brazil TNF Alpha Inhibitors Market

    24.1. Brazil TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24.2. Brazil TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25. Middle East TNF Alpha Inhibitors Market

    25.1. Middle East TNF Alpha Inhibitors Market Overview

    25.2. Middle East TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25.3. Middle East TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26. Africa TNF Alpha Inhibitors Market

    26.1. Africa TNF Alpha Inhibitors Market Overview

    26.2. Africa TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26.3. Africa TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    27. TNF Alpha Inhibitors Market Competitive Landscape And Company Profiles

    27.1. TNF Alpha Inhibitors Market Competitive Landscape

    27.2. TNF Alpha Inhibitors Market Company Profiles

    27.2.1. AbbVie Inc.

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Amgen Inc.

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Johnson & Johnson Services, Inc.

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. UCB S.A

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Novartis International AG

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. TNF Alpha Inhibitors Pipeline Analysis

    29. Key Mergers And Acquisitions In The TNF Alpha Inhibitors Market

    30. TNF Alpha Inhibitors Market Future Outlook and Potential Analysis

    31. Appendix

    31.1. Abbreviations

    31.2. Currencies

    31.3. Research Inquiries

    31.4. The Business Research Company

    31.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Table 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Table 3: Global TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 4: Global TNF Alpha Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 5: Global TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 6: Global TNF Alpha Inhibitors Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 7: Global TNF Alpha Inhibitors Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 8: Asia-Pacific, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 9: Asia-Pacific, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 10: China, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 11: China, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 12: India, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 13: India, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 14: Japan, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 15: Japan, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 16: Australia, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 17: Australia, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 18: Indonesia, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 19: Indonesia, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 20: South Korea, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 21: South Korea, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 22: Western Europe, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 23: Western Europe, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 24: UK, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 25: UK, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 26: Germany, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 27: Germany, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 28: France, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 29: France, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 30: Eastern Europe, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 31: Eastern Europe, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 32: Russia, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 33: Russia, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 34: North America, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 35: North America, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 36: USA, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 37: USA, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 38: South America, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 39: South America, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 40: Brazil, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 41: Brazil, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 42: Middle East, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 43: Middle East, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 44: Africa, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 45: Africa, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 46: AbbVie Inc. Financial Performance
  • Table 47: Amgen Inc. Financial Performance
  • Table 48: Johnson & Johnson Services, Inc. Financial Performance
  • Table 49: UCB S.A Financial Performance
  • Table 50: Novartis International AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Figure 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Figure 3: Global TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 4: Global TNF Alpha Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 5: Global TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 6: Global TNF Alpha Inhibitors Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 7: Global TNF Alpha Inhibitors Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 8: Asia-Pacific, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 9: Asia-Pacific, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 10: China, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 11: China, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 12: India, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 13: India, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 14: Japan, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 15: Japan, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 16: Australia, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 17: Australia, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 18: Indonesia, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 19: Indonesia, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 20: South Korea, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 21: South Korea, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 22: Western Europe, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 23: Western Europe, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 24: UK, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 25: UK, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 26: Germany, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 27: Germany, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 28: France, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 29: France, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 30: Eastern Europe, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 31: Eastern Europe, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 32: Russia, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 33: Russia, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 34: North America, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 35: North America, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 36: USA, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 37: USA, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 38: South America, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 39: South America, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 40: Brazil, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 41: Brazil, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 42: Middle East, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 43: Middle East, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 44: Africa, TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 45: Africa, TNF Alpha Inhibitors Market, Segmentation By Disease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 46: AbbVie Inc. Financial Performance
  • Figure 47: Amgen Inc. Financial Performance
  • Figure 48: Johnson & Johnson Services, Inc. Financial Performance
  • Figure 49: UCB S.A Financial Performance
  • Figure 50: Novartis International AG Financial Performance
Global Anti-Infective Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Cell and Gene Therapy Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Pharmaceutical Drugs And Biologics Logistics Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Pharmaceutical Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Microbiome Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global G-CSF (Granulocyte Colony Stimulating Factors) Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Therapeutic Proteins Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Checkpoint Inhibitors Global Market Report 2021 - By Drug (PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4, Chimeric Antigen Receptor T-cell), By Application (Lung Cancer, Renal Cancer, Blood Cancer, Bladder Cancer, Melanoma), By End-Users (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), COVID-19 Growth And Change
View Report
TNF Alpha Inhibitors Global Market Report 2021 - By Drug (Remicade (Infliximab), Enbrel (Etanercept), Humira (Adalimumab), Cimzia (Certolizumab Pegol), Simponi (Golimumab), By Route Of Administration (Oral, Subcutaneous, Intravenous), By Disease Type (Inflammatory Bowel Disease, Psoriatic Arthritis, Ulcerative Colitis (UC), Rheumatoid Arthritis, Ankylosing Spondylitis), COVID-19 Growth And Change
View Report
Vascular Endothelial Growth Factor (VEGF) Inhibitor Global Market Report 2021 - By Drugs Type (Avastin, Tecentriq, Cometriq, Eylea), By Route Of Administration (Oral, Intravenous), By Application (Oncology, Ophthalmology), COVID-19 Growth And Change
View Report
Interleukin Inhibitors Global Market Report 2021 - By Type (IL-17, IL-23, IL-1, IL-5, IL-6), By Application (Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Asthma, Inflammatory Bowel Disease), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), COVID-19 Growth And Change
View Report
Immunosuppressants Global Market Report 2021 - By Drug Class (Corticosteroids, Monoclonal Antibodies (MAbs), Calcineurin Inhibitors, mTOR Inhibitors, Anti-Proliferative Agents), By Indication (Organ Transplantation, Autoimmune Disorders, Non-Autoimmune Inflammatory Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), COVID-19 Growth And Change
View Report
Antacids Global Market Report 2021 - By Drug Class (Proton Pump Inhibitors, H2 Antagonist, Acid Neutralizers, Pro-Motility Agents), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Formulation Type (Tablet, Liquid, Powder), COVID-19 Impact And Recovery
View Report
Protein Inhibitors Global Market Report 2021 - By Product (Protein Kinase Inhibitors, Monoclonal Antibody), By Application (Oncology, Inflammatory Diseases), By Distribution Channel (Hospital Pharmacies, Independent Pharmacies, Online Pharmacies), COVID-19 Growth And Change
View Report
Vascular Endothelial Growth Factor (VEGF) Inhibitor Market 2021 - By Drug Type (Eylea, Avastin, Tagrisso, Tecentriq), By Route of Administration (Intravenous, Intravitreal, Oral), By Application (Oncology, Ophthalmology), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)